Stock Research for NYMX

NYMX

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

NYMX Stock Chart & Research Data

The NYMX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the NYMX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


NYMX Due diligence Resources & Stock Charts

The NYMX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View NYMX Detailed Price Forecast - CNN Money CNN View NYMX Detailed Summary - Google Finance
Yahoo View NYMX Detailed Summary - Yahoo! Finance Zacks View NYMX Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View NYMX Trends & Analysis - Trade-Ideas Barrons View NYMX Major Holders - Barrons
NASDAQ View NYMX Call Transcripts - NASDAQ Seeking View NYMX Breaking News & Analysis - Seeking Alpha
Spotlight View NYMX Annual Report - CompanySpotlight.com OTC Report View NYMX OTC Short Report - OTCShortReport.com
TradeKing View NYMX Fundamentals - TradeKing Charts View NYMX SEC Filings - Bar Chart
WSJ View Historical Prices for NYMX - The WSJ Morningstar View Performance/Total Return for NYMX - Morningstar
MarketWatch View the Analyst Estimates for NYMX - MarketWatch CNBC View the Earnings History for NYMX - CNBC
StockMarketWatch View the NYMX Earnings - StockMarketWatch MacroAxis View NYMX Buy or Sell Recommendations - MacroAxis
Bullish View the NYMX Bullish Patterns - American Bulls Short Pains View NYMX Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View NYMX Stock Mentions - StockTwits PennyStocks View NYMX Stock Mentions - PennyStockTweets
Twitter View NYMX Stock Mentions - Twitter Invest Hub View NYMX Investment Forum News - Investor Hub
Yahoo View NYMX Stock Mentions - Yahoo! Message Board Seeking Alpha View NYMX Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for NYMX - SECform4.com Insider Cow View Insider Transactions for NYMX - Insider Cow
CNBC View NYMX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for NYMX - OTC Markets
Yahoo View Insider Transactions for NYMX - Yahoo! Finance NASDAQ View Institutional Holdings for NYMX - NASDAQ


Stock Charts

FinViz View NYMX Stock Insight & Charts - FinViz.com StockCharts View NYMX Investment Charts - StockCharts.com
BarChart View NYMX Stock Overview & Charts - BarChart Trading View View NYMX User Generated Charts - Trading View


Latest Financial News for NYMX

NYMOX Successfully Achieves Manufacturing Scale-Up
Posted on Thursday June 07, 2018

HASBROUCK HEIGHTS, N.J., June 07, 2018-- Nymox Pharmaceutical Corporation is pleased to report that manufacturing scale-up milestones have been reached for the Company's lead compound Fexapotide Triflutate. ...


Fexapotide Triflutate Pivotal Phase 3 Study Results Presented and Discussed at American Urological Association Annual Meeting in San Francisco
Posted on Tuesday May 22, 2018

Nymox Pharmaceutical Corporation (NYMX) is pleased to report on a successful symposium discussing Nymox’s lead product candidate Fexapotide Triflutate (FT) as a novel therapeutic option in BPH at the Annual Meeting of the American Urological Association in San Francisco, this past weekend. Dr. Ronald Tutrone of Chesapeake Urology Research Associates, Baltimore MD, and a principal investigator in the trials, chaired the meeting and presented clinically relevant therapeutic highlights from the trials.


Nymox: 1Q Earnings Snapshot
Posted on Wednesday May 16, 2018

On a per-share basis, the St.-Laurent, Quebec-based company said it had a loss of 5 cents. The biopharmaceutical company posted revenue of $152,000 in the period. The company's shares closed at $3.92. ...


Nymox’s Fexapotide Featured in Broadcast of Grand Rounds in Urology
Posted on Friday May 11, 2018

Nymox Pharmaceutical Corporation (NYMX) is pleased to announce that an informative interview and presentation was released on Grand Rounds in Urology, a highly respected and authoritative urologic professional community, and host of international conferences and symposia that bring together the top thought leaders in the treatment of urologic disease, with meetings that focus on current best treatment practices as well as future trends and directions. Grand Rounds in Urology is hosted and edited by Dr. E. David Crawford of the University of Colorado. Dr. Crawford is an international expert in urological research who is a Professor of Surgery, Urology, and Radiation Oncology, and Head of the Section of Urologic Oncology at the University of Colorado, Denver CO. The presentation was given by Dr. Ronald Tutrone Jr., MD FACS of Chesapeake Urology Research Associates, Towson, MD.


Enter a stock symbol to view the stock details.